Amoxicillin 1g Powder for Solution for Injection
- Revised
- 09/05/2024
- Source updated
- 16 May 2024
- MA number
- Amoxicillin 250mg Powder for Solution for Injection - PL 29831/0010 Amoxicillin 500mg Powder for Solution for Injection - PL 29831/0012 Amoxicillin 1g Powder for Solution for Injection - PL 29831/0011
- ATC
- J01CA04
- Legal status
- Prescription only medicine
Indications
Concepts (25)
+Allergy to the medicineContraindicated
Hypersensitivity to the active substance, to any of the penicillins or to any of the excipients listed in section 6.1. History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam).
Source SmPC ↗+Heart conditionsWarning
tiating therapy with amoxicillin, careful enquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins or other beta-lactam agents (see sections 4.3 and 4.8). Serious and occasionally fatal hypersensitivity reactions (including anaphylactoid and severe cutaneous adverse reactions) have been reported in patients on penicillin therapy. Hypersensitivity reactions can also progress to Kounis syndrome, a serious allergic reaction that can result in myocardial infarction (see section 4.8). These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity and in atopic individuals. If an allergic reaction occurs, amoxicillin therapy must be discontinued and appropriate alternative therapy instituted. Drug-induced enterocolitis syndrome (DIES) has been reported mainly in children receiving amoxicillin (see section 4.8). DIES is an allergic reaction with the leading symptom of protracted vomiting
Storage and shelf life
§6.3 — Shelf life
3 years
§6.4 — Special precautions for storage
Store below 25°C.
Reconstituted solutions should be administered immediately after preparation.